The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


AZN ASTRAZENECA PLC ORD SHS $0.25

ASTRAZENECA  Currency  GBX  Premium Equity Commercial Companies



 Page 1 of 11

| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next |

Time/Date Code Headline Source Impact
17:00 19-Nov-2014 AZN Launch and Pricing of a EUR750m Bond RNS +1.45% Up
07:00 18-Nov-2014 AZN AZ strategy on track to deliver growth and value RNS +1.28% Up
16:00 17-Nov-2014 AZN Publication of Supplementary Prospectus RNS +0.66% Up
07:00 12-Nov-2014 AZN AMGEN & AZ POSITIVE PHASE III BRODALUMAB RESULTS RNS +1.22% Up
14:27 10-Nov-2014 AZN Director/PDMR Shareholding RNS +1.95% Up
07:04 06-Nov-2014 AZN ASTRAZENECA TO DIVEST MYALEPT TO AEGERION RNS +1.72% Up
07:00 06-Nov-2014 AZN 3rd Quarter Results RNS +1.72% Up
07:00 06-Nov-2014 AZN 3rd Quarter Results RNS +1.72% Up
07:00 05-Nov-2014 AZN Notice of Results RNS +2.20% Up
07:00 04-Nov-2014 AZN MEDIMMUNE ACQUIRES DEFINIENS RNS +2.62% Up
15:00 03-Nov-2014 AZN Total Voting Rights RNS +2.92% Up
07:00 03-Nov-2014 AZN AZ COMPLETES STRATEGIC TRANSACTION WITH ALMIRALL RNS +2.92% Up
07:00 30-Oct-2014 AZN US FDA APPROVES ONCE-DAILY XIGDUOT XR TABLETS RNS +4.05% Up
12:10 24-Oct-2014 AZN Olaparib receives positive CHMP opinion RNS +3.73% Up
15:30 02-Oct-2014 AZN Director/PDMR Shareholding RNS -2.09% Down
16:00 01-Oct-2014 AZN Total Voting Rights RNS -1.79% Down
07:00 29-Sep-2014 AZN ASTRAZENECA UPDATES ON ONCOLOGY PIPELINE AT ESMO RNS -1.27% Down
11:15 26-Sep-2014 AZN Positive CHMP Opinion for MOVENTIG (naloxegol) RNS -1.81% Down
16:27 16-Sep-2014 AZN FDA Approves MOVANTIK (naloxegol) Tablets RNS -0.37% Down
07:00 16-Sep-2014 AZN AZ AND LILLY ALLIANCE TO DEVELOP BACE INHIBITOR RNS -0.37% Down

 Page 1 of 11

| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next |

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released, including the day of the release of the news
y = instrument's latest 7 closing prices before the news was released

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank " - " next to the line indicating the RNS issue.


ASTRAZENECA share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds